Grazia Arpino Sabino De Placido Carmine De Angelis
10.1097/CAD.0000000000000159
Anticancer Drugs
2015 Jan;26(1):117-22.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/25115342/
Antineoplastic Agents / therapeutic use Triple Negative Breast Neoplasms / drug therapy
Antineoplastic Agents / therapeutic use Triple Negative Breast Neoplasms / drug therapy Case Reports Research Support, Non-U.S. Gov't Albumins / administration & dosage Antineoplastic Agents / administration & dosage Bevacizumab / administration & dosage Female Humans Middle Aged Nanoparticles Neoplasm Metastasis Paclitaxel / administration & dosage Triple Negative Breast Neoplasms / pathology 130-nm albumin-bound paclitaxel Albumins Antineoplastic Agents Bevacizumab Paclitaxel
PMC4243802
25115342
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
2015